Risks

Negative interest coverage and a current ratio near 1.0 leave ARQ more exposed than larger peers if pricing weakens or working capital tightens, despite low leverage.

A 75.8-day cash conversion cycle and 59.2-day receivables collection imply working-capital drag that can pressure liquidity and free cash flow versus faster-turning peers.

Inventory days of 80.6 and payables of 64.0 suggest capital is tied up longer than in leaner specialty-materials peers, limiting flexibility if demand softens.

Low debt-to-equity reduces balance-sheet risk, but ARQ’s thin liquidity cushion means any margin compression or customer delays would transmit faster to outcomes than at better-capitalized peers.

Opportunities

Net debt to EBITDA is negative, giving ARQ more financial flexibility than leveraged peers to absorb volatility and fund working-capital needs without immediate refinancing pressure.

Low debt-to-equity supports resilience versus more levered specialty-chemical peers, improving ARQ’s ability to preserve operating capacity through cyclical demand swings.

If end-market demand stabilizes, ARQ’s modest leverage can translate incremental operating improvement into equity value faster than peers carrying heavier interest burdens.

Working-capital normalization would release cash and improve liquidity, creating upside that is more immediate for ARQ than for peers already operating with tighter cash cycles.

Overall Score

ARQ’s low leverage and negative net debt provide meaningful peer-relative flexibility, but weak liquidity and a long cash conversion cycle remain the main constraints on near-term realization.